- Home
- NXPI vs EW Comparison
NXPI vs EW Comparison
Compare NXPI & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPI
- EW
- Stock Information
- Founded
- NXPI 2006
- EW 1958
- Country
- NXPI Netherlands
- EW United States
- Employees
- NXPI N/A
- EW N/A
- Industry
- NXPI Semiconductors
- EW Industrial Specialties
- Sector
- NXPI Technology
- EW Health Care
- Exchange
- NXPI Nasdaq
- EW Nasdaq
- Market Cap
- NXPI 49.6B
- EW 40.7B
- IPO Year
- NXPI 2010
- EW 2000
- Fundamental
- Price
- NXPI $191.88
- EW $73.68
- Analyst Decision
- NXPI Strong Buy
- EW Buy
- Analyst Count
- NXPI 19
- EW 20
- Target Price
- NXPI $254.84
- EW $79.45
- AVG Volume (30 Days)
- NXPI 3.2M
- EW 4.3M
- Earning Date
- NXPI 04-28-2025
- EW 04-23-2025
- Dividend Yield
- NXPI 2.11%
- EW N/A
- EPS Growth
- NXPI N/A
- EW 201.77
- EPS
- NXPI 9.18
- EW 7.02
- Revenue
- NXPI $12,323,000,000.00
- EW $5,522,300,000.00
- Revenue This Year
- NXPI N/A
- EW $10.07
- Revenue Next Year
- NXPI $10.23
- EW $9.65
- P/E Ratio
- NXPI $20.53
- EW $10.54
- Revenue Growth
- NXPI N/A
- EW N/A
- 52 Week Low
- NXPI $148.09
- EW $58.93
- 52 Week High
- NXPI $296.08
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- NXPI 54.68
- EW 52.18
- Support Level
- NXPI $180.63
- EW $74.25
- Resistance Level
- NXPI $191.61
- EW $76.13
- Average True Range (ATR)
- NXPI 6.12
- EW 1.75
- MACD
- NXPI 1.82
- EW -0.02
- Stochastic Oscillator
- NXPI 75.87
- EW 56.51
About NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.